Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: At what point did TPL become co-OWNER

The more I read the more confusing things appear

From Moore's complaint (see page 11)

TPL wrongfully converted in or about October 2003 to its own possession and use ALL right, title and interest in the MMP portfolio, through filings with the USPTO, failing to advise Moore. Moore was unaware of TPL's wrongful appropriation of the MMP portfolio until August 2008 when Moore's review of PTO records revealed that Leckrone filed assignment papers with the PTO assigning all rights to the MMP portfolio to TPL.

If TPL did this in October 2003 and PTSC filed a suit against TPL & Moore in Feb 2004, would it seem reasonable that discovery of this fact would have come out sometime between Feb 2004 and June 2005 when we settled with Moore and TPL?

Again I will state what was taken from the Master Agreement signed in June 2005

4.6 Intellectual Property

(a) TPL has a valid and subsisting license to the MSD Patents from

Moore. Except as disclosed on Schedule 4.6(a), TPL has not received any notice

or claim challenging TPL's rights with respect to the MSD Patents or suggesting

that any Person, other than Patriot and Moore, has any claim of legal or

beneficial ownership with respect thereto, nor, to TPL's knowledge, is there a

reasonable basis for any such claim.

Will the real and lawful owners of the MMP portfolio please come forward.

Share
New Message
Please login to post a reply